{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:36:19Z","timestamp":1793957779926,"version":"4.8.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Despite deranged coagulation, children with liver disease undergoing continuous renal replacement therapy (CRRT) are prone to circuit clotting. Commonly used anticoagulants (i.e., heparin and citrate) can have side effects. The aim of this study was to describe our experience of using epoprostenol (a synthetic prostacyclin analog) as a sole anticoagulant during CRRT in children with liver disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Single-center, retrospective study, 2010\u20132019.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Sixteen-bedded PICU within a United Kingdom supra-regional center for pediatric hepatology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Children with liver disease admitted to PICU who underwent CRRT anticoagulation with epoprostenol.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Regarding CRRT, we assessed filter life duration, effective 60-hour filter survival, and effective solute clearance. We also assessed the frequency of major or minor bleeding episodes per 1,000 hours of CRRT, the use of platelet and RBC transfusions, and the frequency of hypotensive episodes per 1,000 hours of CRRT. In the 10 years 2010\u20132019, we used epoprostenol anticoagulation during 353 filter episodes of CRRT, lasting 18,508 hours, in 96 patients (over 108 admissions). Median (interquartile range [IQR]) filter life was 48 (IQR 32\u201372) hours, and 22.9% of filters clotted. Effective 60-hour filter survival was 60.5%.We identified that 5.9% of filters were complicated by major bleeding (1.13 episodes per 1,000\u2009hr of CRRT), 5.1% (0.97 per 1,000\u2009hr) by minor bleeding, and 11.6% (2.22 per 1,000\u2009hr) by hypotension. There were no differences in filter life or clotting between patients with acute liver failure and other liver diseases; there were no differences in rates of bleeding, hypotension, or transfusion when comparing patients with initial platelets of \u2264 50\u2009\u00d7\u200910<jats:sup>9<\/jats:sup> per liter to those with a higher initial count.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Epoprostenol, or prostacyclin, as the sole anticoagulant for children with liver disease receiving CRRT in PICU, results in a good circuit life, and complications such as bleeding and hypotension are similar to reports using other anticoagulants, despite concerns about coagulopathy in this cohort.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003371","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T15:00:19Z","timestamp":1704294019000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Epoprostenol (Prostacyclin Analog) as a Sole Anticoagulant in Continuous Renal Replacement Therapy for Critically Ill Children With Liver Disease: Single-Center Retrospective Study, 2010\u20132019*"],"prefix":"10.1097","volume":"25","author":[{"given":"Akash","family":"Deep","sequence":"first","affiliation":[{"name":"Department of Women and Children\u2019s Health, School of Life Course Sciences, King\u2019s College London, London, United Kingdom."},{"name":"Paediatric Intensive Care Unit, King\u2019s College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma C.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit, King\u2019s College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Khatri","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit, King\u2019s College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Kumari","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit, King\u2019s College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan","family":"Sudheendhra","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit, King\u2019s College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithvi","family":"Patel","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit, King\u2019s College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Joarder","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit, King\u2019s College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Elghuwael","sequence":"additional","affiliation":[{"name":"Paediatric Intensive Care Unit, King\u2019s College Hospital NHS Foundation Trust, Denmark Hill, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S2352-4642(22)00190-0","article-title":"Advances in medical management of acute liver failure in children: Promoting native liver survival.","volume":"6","author":"Deep","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41581-020-0267-8","article-title":"Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy.","volume":"16","author":"Raina","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00467-018-3893-7","article-title":"Acute kidney injury in children with chronic liver disease.","volume":"34","author":"Deep","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"455","DOI":"10.23876\/j.krcp.19.060","article-title":"Basics of continuous renal replacement therapy in pediatrics.","volume":"38","author":"John","year":"2019","journal-title":"Kidney Res Clin Pract"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13613-020-0648-y","article-title":"Prescription of CRRT: A pathway to optimize therapy.","volume":"10","author":"Karkar","year":"2020","journal-title":"Ann Intensive Care"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/PCC.0000000000002305","article-title":"The effect of patient- and treatment-related factors on circuit lifespan during continuous renal replacement therapy in critically ill children.","volume":"21","author":"Cortina","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00467-022-05567-5","article-title":"Anticoagulation strategies in continuous kidney replacement therapy\u2014does one size fit all?","volume":"37","author":"Deep","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"e0182134","DOI":"10.1371\/journal.pone.0182134","article-title":"Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.","volume":"12","author":"Rodriguez","year":"2017","journal-title":"PLoS One"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"618119","DOI":"10.3389\/fped.2020.618119","article-title":"Hemostatic balance in pediatric acute liver failure: Epidemiology of bleeding and thrombosis, physiology, and current strategies.","volume":"8","author":"Bulut","year":"2020","journal-title":"Front Pediatr"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cld.976","article-title":"Current concepts in coagulation profile in cirrhosis and acute-on-chronic liver failure.","volume":"16","author":"Premkumar","year":"2020","journal-title":"Clin Liver Dis"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"fmac048","DOI":"10.1093\/tropej\/fmac048","article-title":"Continuous renal replacement therapy with regional citrate anticoagulation in children with liver dysfunction\/failure.","volume":"68","author":"Botan","year":"2022","journal-title":"J Trop Pediatr"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/ajt.15748","article-title":"Evidence for a rebalanced hemostatic system in pediatric liver transplantation: A prospective cohort study.","volume":"20","author":"Werner","year":"2020","journal-title":"Am J Transplant"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.thromres.2020.02.008","article-title":"Thrombin dynamics in children with liver disease or extrahepatic portal vein obstruction or shunt.","volume":"188","author":"Beattie","year":"2020","journal-title":"Thromb Res"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0885066621992751","article-title":"A meta-analysis of extracorporeal anticoagulants in pediatric continuous kidney replacement therapy.","volume":"37","author":"Raina","year":"2021","journal-title":"J Intensive Care Med"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/jth.15330","article-title":"Multidimensional flow cytometry reveals novel platelet subpopulations in response to prostacyclin.","volume":"19","author":"Hindle","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R16-20250502","first-page":"e39967","article-title":"Efficacy of prostacyclin anticoagulation in critically ill patients requiring extracorporeal support: A systematic review and meta-analysis.","volume":"15","author":"Aldairi","year":"2023","journal-title":"Cureus"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/1744-9987.12224","article-title":"Factors affecting circuit life during continuous renal replacement therapy in children with liver failure.","volume":"19","author":"Goonasekera","year":"2015","journal-title":"Ther Apher Dial"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s00467-022-05502-8","article-title":"Comparison of nafamostat mesilate to citrate anticoagulation in pediatric continuous kidney replacement therapy.","volume":"37","author":"Miyaji","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/MPG.0000000000001721","article-title":"Coagulopathy in children with liver disease.","volume":"65","author":"Kawada","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"e2246901","DOI":"10.1001\/jamanetworkopen.2022.46901","article-title":"Continuous kidney replacement therapy practices in pediatric intensive care units across Europe.","volume":"5","author":"Daverio","year":"2022","journal-title":"JAMA Network Open"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-002-1249-y","article-title":"Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent.","volume":"28","author":"Fiaccadori","year":"2002","journal-title":"Intensive Care Med"}],"updated-by":[{"DOI":"10.1097\/pcc.0000000000003472","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000}}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:11:03Z","timestamp":1746205863000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003371","relation":{"correction":[{"id-type":"doi","id":"10.1097\/PCC.0000000000003472","asserted-by":"object"}]},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}